In Vivo Toxicology Market Scenario
Upsurge in pharmaceutical R&D activities, innovations in animal models and the development of exclusive in vivo toxicology tests are some of the major factors propelling the In Vivo Toxicology market globally. Furthermore, growing demand for personalized medicine is also one of the factor augmenting the growth of In Vivo Toxicology market. However, alternatives to animal testing is one of the major factor expected to hamper the global growth of the In Vivo Toxicology market.
In Vivo Toxicology Market Segmentation
The In Vivo Toxicology market is segmented by Product, Test Type, Testing Facility, Toxicity Endpoint, End User and Geography. Various products studied in the report are Consumables (Reagents & Kits and Animal Models (Mice Models, Rat Models and Other Animal Models) and Instruments. Furthermore, the Test Type comprises of Acute Toxicity Testing, Chronic Toxicity Testing, Sub-Acute Toxicity Testing and Sub-Chronic Toxicity Testing. Moreover, the Testing Facility includes Outsourced Testing Facilities and In-House Testing Facilities. Likewise, the Toxicity Endpoint covers Carcinogenicity, Developmental & Reproductive Toxicity, Genotoxicity, Immunotoxicity, Systemic Toxicity and Other Toxicity Endpoints. In addition, the End User of In Vivo Toxicology are Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Other End Users. Based on Geography, the In Vivo Toxicology Market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW.
In Vivo Toxicology Market by Geography
Geographically, the In Vivo Toxicology market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America is expected to account for the largest market share. The government funding for life sciences research, growth in stem cell research activities and increasing focus on cancer research are supporting market growth in the region.
In Vivo Toxicology Market Key Players
Some of the major players operating in the global In Vivo Toxicology market includes Agilent Technologies, Bio-Rad Laboratories, Bruker Corporation, Charles River Laboratories, Crown Bioscience, Danaher Corporation, Envigo, Genoway, Harbour Biomed, Ozgene Pty Ltd., Perkinelmer, Shimadzu Corporation, Taconic Biosciences, The Jackson Laboratory, Thermo Fisher Scientific, Transcure Bioservices and Waters Corporation. These players are focusing on innovation as well as research & development in order to gain a higher share in the market to enhance their position in the market.
In Vivo Toxicology Market Report Key Benefits